New Metrics For Clinical Trial Oversight Floated By CDRH Entrepreneurs In Residence

Variability runs high in FDA’s process for approving new device trials, but the agency is open to recommendations for improvements coming out of its entrepreneurs-in-residence program, says Chip Hance, a former Abbott executive participating in the program.